Broadcom vs. Qualcomm: Buy One, Avoid the Other — Negative
AVGO QCOM 24/7 Wall Street — April 09, 2026Broadcom (NASDAQ:AVGO | AVGO Price Prediction) and Qualcomm (NASDAQ:QCOM) both reported earnings recently, revealing a sharp divergence.
Warner Music Group set to benefit from pricing gains and streaming momentum in 2026, says UBS — Positive
WMG Proactive Investors — April 09, 2026Warner Music Group Corp (NASDAQ:WMG) is expected to deliver stronger revenue growth and improved margins over the coming fiscal year, according to a recent note from analysts at UBS, who point to rising subscription revenues and emerging artificial intelligence (AI) partnerships as key drivers. The analysts project that fiscal 2026 could mark an inflection point for the music company.
Price Prediction: Rivian Stock Eyes Comeback After 2026 Slump — Neutral
RIVN 24/7 Wall Street — April 09, 2026Rivian Automotive (NASDAQ:RIVN | RIVN Price Prediction) trades at $14.94 as of writing, sitting 20% below its 52-week high of $22.69 and down 24.2% year to date.
CubeSmart: A Historically High Yield, But Still A Hold — Positive
CUBE Seeking Alpha — April 09, 2026CubeSmart (CUBE) offers a 5.8% yield near historic highs, but growth prospects are limited for several years. With an 87% AFFO payout ratio and a manageable 4.8x Debt/EBITDA, CUBE's dividend is stable but leaves little room for increases. Valuation at 15x P/FFO and ~$36/share is fair, with minimal margin of safety and no compelling undervaluation.
Apollo Global Management, Inc. (APO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit — Neutral
APO PRNewsWire — April 09, 2026LOS ANGELES, April 9, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Apollo Global Management, Inc. ("Apollo" or the "Company") (NYSE: APO) have opportunity to lead the securities fraud class action lawsuit.
Nektar Therapeutics (NKTR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit — Neutral
NKTR PRNewsWire — April 09, 2026LOS ANGELES, April 9, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Nektar Therapeutics ("Nektar" or the "Company") (NASDAQ: NKTR) have opportunity to lead the securities fraud class action lawsuit.
Did The Trade Desk, Inc. Insiders Breach their Fiduciary Duties to Shareholders? — Neutral
TTD PRNewsWire — April 09, 2026Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
KD Deadline: KD Investors Have Opportunity to Lead Kyndryl Holdings, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm — Neutral
KD PRNewsWire — April 09, 2026NEW YORK, April 9, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Kyndryl Holdings, Inc. (NYSE: KD) between August 7, 2024 and February 9, 2026, both dates inclusive (the "Class Period"), of the important April 13, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. So what: If you purchased Kyndryl securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Did Humacyte, Inc. Insiders Breach their Fiduciary Duties to Shareholders? — Neutral
HUMA PRNewsWire — April 09, 2026Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
monday.com Ltd. (MNDY) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit — Neutral
MNDY PRNewsWire — April 09, 2026LOS ANGELES, April 9, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to monday.com Ltd.
Nurix: 'Strong Buy' Bexobruditeg Development And Dual Degrader Zelebrudomide — Positive
NRIX Seeking Alpha — April 09, 2026Nurix Therapeutics, Inc. maintains a Strong Buy rating, driven by the advancement of bexobrutideg for relapsed/refractory CLL in pivotal phase 2 trials. Company is set to initiate a global phase 3 confirmatory trial for bexobrutideg in mid-2026, targeting patients post-BTK therapy and benchmarking against pirtobrutinib. Expansion efforts include higher-dose bexobrutideg for earlier CLL lines, an oral formulation for immunology, and the dual BTK/IKZF degrader zelebrudomide for B-cell malignancies.
Raising cash in portfolio amid market uncertainty: Janus Henderson's Richard Bernstein — Neutral
JHG CNBC Television — April 09, 2026Richard Bernstein, Janus Henderson, joins 'The Exchange' to discuss Bernstein's view on equity market positioning, when to invest and much more.
Gemini Space Station, Inc. (GEMI) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit — Neutral
GEMI PRNewsWire — April 09, 2026BENSALEM, Pa., April 9, 2026 /PRNewswire/ -- The Law Offices of Howard G.
ROSEN, A TOP-RANKED LAW FIRM, Encourages Enphase Energy, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ENPH — Neutral
ENPH GlobeNewsWire — April 09, 2026NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Enphase Energy, Inc. (NASDAQ: ENPH) between April 22, 2025 and October 28, 2025, inclusive (the “Class Period”), of the important April 20, 2026 lead plaintiff deadline.
Exclusive: Shell seeks to begin gas output at massive Venezuela-Trinidad Loran Manatee field next year — Positive
SHEL Reuters — April 09, 2026Energy producer Shell plans to begin natural gas output in 2027 from the Loran-Manatee offshore field, which crosses the border of Venezuela and Trinidad and Tobago the chairman of Trinidad's National Gas Company, Gerald Ramdeen, told Reuters on Thursday.
JPMorgan Chase: Earnings Offer Catalyst Opportunity For Shares — Positive
JPM Seeking Alpha — April 09, 2026JPMorgan Chase & Co. remains a "Buy" ahead of Q1 earnings, supported by macroeconomic optimism and resilient sector fundamentals. I expect modest balance sheet growth, with lending up around 2% and deposits rising 1%, reflecting sector trends. Net interest income should improve, as stable yield spreads and steady loan/deposit growth offset recent volatility.
Trip.com Group (TCOM) Shares Crater Amid Questions Over AI Price Adjustment Tool, Anti-Monopoly Regulatory Probe; Securities Class Action Pending -- Hagens Berman — Neutral
TCOM PRNewsWire — April 09, 2026SAN FRANCISCO, April 9, 2026 /PRNewswire/ -- A securities class action lawsuit has been filed against China's largest online travel agency, Trip.com Group (NASDAQ: TCOM), seeking to represent investors who purchased Trip.com securities between April 30, 2024 and January 13, 2026. The lawsuit follows the 17% decline in the price of Trip.com American Depositary Shares on January 14, 2026.
Bragar Eagel & Squire, P.C. Announces that Super Micro Computer, Inc. Investors Have Until May 26th to Seek Role as Lead Plaintiff — Neutral
SMCI GlobeNewsWire — April 09, 2026Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Super Mirco (SMCI) To Contact Him Directly To Discuss Their Options
Signal: Crypto Mining Stock Could Have Room to Run — Positive
CIFR Schaeffers Research — April 09, 2026When we last covered Cipher Mining Inc (NASDAQ:CIFR), the crypto mining stock was trading at all-time highs around $25.52 in early November.
Royal Bank of Canada (RY:CA) Shareholder/Analyst Call Transcript — Neutral
RY Seeking Alpha — April 09, 2026Royal Bank of Canada (RY:CA) Shareholder/Analyst Call Transcript